CCME Global logo

CCME Global results

BSE: 514336Pharmaceuticals & BiotechnologySmall Cap

Last close ₹30.22down ₹1.59 (5.00%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹31.81.

52-week range of traded prices to 23 Oct 2026
₹26.41Low, 9 Sep 2026₹184.90High, 11 Nov 2025
Market cap
₹137 Cr2,307th largest listed
P/E
Lossover the last 12 months
P/B
Shares changed
Dividend yield
Nonein the last 12 months
ROE
−3.5%
ROCE
−2.2%
Debt to equity
0.00
Volume, BSE
1,296

Q1 results, quarter to Jun 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.CCME Global annual results and balance sheet

Revenue
₹0.00 Cr
Operating profit
−₹0.24 Cr
Net profit
−₹0.26 Cr
Earnings per share
−₹0.06

From revenue to net profit, ₹ crore

  1. Revenue0.0
  2. Employee costs−0.1
  3. Other expenses−0.2
  4. Operating profit−0.2
  5. Depreciation0.0
  6. Other income0.0
  7. Finance costs0.0
  8. Profit before tax−0.3
  9. Tax0.0
  10. Net profit−0.3

CCME Global results by quarter

Standalone: the listed company alone, without its subsidiaries. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
  • Loss

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
₹ croreSep 2021Q2Filed 19 NovDec 2021Q3Filed 15 FebMar 2022Q4Filed 13 JunJun 2022Q1Filed 25 NovSep 2022Q2Filed 25 NovDec 2022Q3Filed 7 FebMar 2023Q4Filed 23 MayJun 2023Q1Filed 8 AugSep 2023Q2Filed 30 NovDec 2023Q3Filed 23 FebMar 2024Q4Filed 1 JulJun 2024Q1Filed 19 SepSep 2024Q2Filed 14 NovDec 2024Q3Filed 14 FebMar 2025Q4Filed 13 JunJun 2025Q1Filed 14 AugSep 2025Q2Filed 14 NovDec 2025Q3Filed 14 FebMar 2026Q4Filed 29 MayJun 2026Q1Filed 14 Aug
Revenue from operations0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
0.020.020.030.050.010.020.050.060.020.023.690.100.020.030.020.120.060.030.540.24
Materials and goods bought0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Employee costs0.010.010.010.000.010.010.000.010.010.010.010.010.010.020.020.040.050.020.000.07
Other expenses0.010.010.020.050.010.010.050.060.010.013.680.090.010.010.010.080.010.010.540.17
Operating profit before depreciation−0.02−0.02−0.03−0.05−0.01−0.02−0.05−0.06−0.02−0.02−3.69−0.10−0.02−0.03−0.02−0.12−0.06−0.03−0.54−0.24
Depreciation and amortisation0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.02
Other income0.000.000.000.000.000.000.000.000.000.000.000.003.670.000.000.000.000.000.040.00
Finance costs0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
One-off items0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax−0.02−0.02−0.03−0.05−0.01−0.02−0.05−0.06−0.02−0.02−3.69−0.103.65−0.03−0.02−0.12−0.06−0.03−0.50−0.26
Tax0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Tax rate––––––––––––0.0%–––––––
Net profit−0.02−0.02−0.03−0.05−0.01−0.02−0.05−0.06−0.02−0.02−3.69−0.103.65−0.03−0.02−0.12−0.06−0.03−0.50−0.26
Earnings per share−₹0.01−₹0.01−₹0.02–−₹0.01−₹0.02−₹0.04−₹0.05−₹0.02−₹0.02−₹2.84−₹0.07₹2.81−₹0.20−₹0.02−₹0.09−₹0.05−₹0.02−₹0.37−₹0.06
Earnings per share in rupees, restated for later splits and bonuses.

The quarter to Jun 2022 was restated in the company's filing of 25 Nov 2022. The table shows the restated figures.

Filed results, as an XML file each

16 earlier filings